Condition
Surveillance Colonoscopy
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Not Yet Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07378930Not ApplicableNot Yet Recruiting
ULTRA-high-risk Surveillance to Avoid Future Events: the ULTRA-SAFE Trial
NCT06568523Not ApplicableNot Yet Recruiting
Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy.
NCT04640792Not ApplicableCompleted
A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy
NCT04034563Not ApplicableUnknownPrimary
Post-polypectomy Surveillance Interval In High-risk Subjects After Screening Colonoscopy
NCT01838408Not ApplicableCompleted
Evaluation of Proposed EZ2go Complete Bowel Cleansing System
Showing all 5 trials